Nymox (NYMX) Reports Strong Data from Follow-Up Assessment of NX-1207 in BPH Patients
Go back to Nymox (NYMX) Reports Strong Data from Follow-Up Assessment of NX-1207 in BPH Patients| Nymox Pharmaceutical Corp (NASDAQ: NYMX) | Delayed: 0.20 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.20 | 52 Week High | $5.79 | |||
| Open | $8.39 | 52 Week Low | $1.62 | |||
| Day High | $0.20 | P/E | N/A | |||
| Day Low | $0.20 | EPS | $-0.18 | |||
| Volume | 236,345 | |||||
